Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Millie Long, MD
Conference Coverage
New Therapies in Managing Ulcerative Colitis: Dr Millie Long
06/21/2023
Dr Millie Long reviewed the updates in the management of ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the updates in the management of ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the...
06/21/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

David Rubin
Conference Coverage
Colorectal Cancer in IBD: David Rubin, MD, on Natural History and Prevention
06/16/2023
David Rubin, MD, reviewed the risk factors and opportunities for early detection and control of dysplasia among patients with inflammatory bowel disease in his presentation to the Advances in Inflammatory Bowel Diseases regional meeting.
David Rubin, MD, reviewed the risk factors and opportunities for early detection and control of dysplasia among patients with inflammatory bowel disease in his presentation to the Advances in Inflammatory Bowel Diseases regional meeting.
David Rubin, MD, reviewed the...
06/16/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti
Conference Coverage
Jessica Allegretti, MD, on Optimizing Existing Therapies in IBD
06/16/2023
Dr Allegretti provides an overview of how new therapies available for the treatment of ulcerative colitis present more choices than ever before, but also require care in selecting and positioning these medications.
Dr Allegretti provides an overview of how new therapies available for the treatment of ulcerative colitis present more choices than ever before, but also require care in selecting and positioning these medications.
Dr Allegretti provides an...
06/16/2023
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Efficacy and Safety of JAK Inhibitors for IBD
06/16/2023
Dr Rubin reviewed data from a variety of studies of Janus kinase inhibitors in the treatment of inflammatory bowel disease and suggested practical approaches to the use of these novel small molecule therapies.
Dr Rubin reviewed data from a variety of studies of Janus kinase inhibitors in the treatment of inflammatory bowel disease and suggested practical approaches to the use of these novel small molecule therapies.
Dr Rubin reviewed data from a...
06/16/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Florian Rieder, MD
Conference Coverage
Florian Rieder, MD, on Biologic Agents in IBD Management
06/16/2023
Florian Rieder, MD, addressed the optimal positioning of antitumor necrosis factors and anti-integrins among patients with Crohn disease and ulcerative colitis.
Florian Rieder, MD, addressed the optimal positioning of antitumor necrosis factors and anti-integrins among patients with Crohn disease and ulcerative colitis.
Florian Rieder, MD, addressed...
06/16/2023
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Conference Coverage
Millie Long, MD, Stresses Shared Decision-Making in the Treatment of UC
06/15/2023
Optimizing therapies to reach predefined goals, including biologic as well as symptomatic targets, could help achieve remission among patients with ulcerative colitis, Dr Long said at the AIBD regional meeting.
Optimizing therapies to reach predefined goals, including biologic as well as symptomatic targets, could help achieve remission among patients with ulcerative colitis, Dr Long said at the AIBD regional meeting.
Optimizing therapies to reach...
06/15/2023
Advances in Inflammatory Bowel Disease Network
Stefan Holubar, MD
Conference Coverage
Stefan Holubar, MD, on Advances in the Management of Fistulizing CD
06/15/2023
Stefan Holubar, MD, emphasized the need to implement coordinated, patient-centered management strategies based on the most current evidence and consensus-based guidelines in managing fistulizing Crohn disease.
Stefan Holubar, MD, emphasized the need to implement coordinated, patient-centered management strategies based on the most current evidence and consensus-based guidelines in managing fistulizing Crohn disease.
Stefan Holubar, MD, emphasized...
06/15/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Corey Siegel, MD
Conference Coverage
Corey Siegel, MD, on Balancing Evidence-Based Medicine with Personalized Care for Crohn's Disease
05/24/2023
Dr Siegel addressed the audience on the need to combine evidence-based medicine from guidelines and research with clinical experience and patient preferences to achieve the best outcomes for patients with Crohn's disease.
Dr Siegel addressed the audience on the need to combine evidence-based medicine from guidelines and research with clinical experience and patient preferences to achieve the best outcomes for patients with Crohn's disease.
Dr Siegel addressed the audience...
05/24/2023
Advances in Inflammatory Bowel Disease Network
Jordan Axelrad, MD
Conference Coverage
Jordan Axelrad, MD, on the Safety of Immune Suppression Among IBD Patients With A History of Cancer
05/18/2023
Dr Axelrad reviews data from the SAPPHIRE registry, which studied whether exposure to IBD therapies after an index cancer increases risk of new or recurrent cancer among patients with IBD.
Dr Axelrad reviews data from the SAPPHIRE registry, which studied whether exposure to IBD therapies after an index cancer increases risk of new or recurrent cancer among patients with IBD.
Dr Axelrad reviews data from the...
05/18/2023
Advances in Inflammatory Bowel Disease Network
Gil Kaplan, MD
Conference Coverage
Gilaad Kaplan, MD, on the Global Burden of IBD
05/09/2023
Dr Kaplan recaps his address on the global burden of inflammatory bowel disease and how incidence and prevalence are rising in developing nations while slowing in the Western world.
Dr Kaplan recaps his address on the global burden of inflammatory bowel disease and how incidence and prevalence are rising in developing nations while slowing in the Western world.
Dr Kaplan recaps his address on...
05/09/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Latest News

News
Impact of Concomitant Medications on Advanced Therapies for Ulcerative Colitis
11/12/2024
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do not affect the efficacy or safety of advanced therapies in ulcerative colitis clinical trials, according to a recent study.
Most concomitant medications do...
11/12/2024
Advances in Inflammatory Bowel Disease Network
News
Assessing Transmural Healing and Response in Patients with Crohn's Disease
11/11/2024
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score was found to be an easy-to-use tool for assessing transmural healing and transmural response in CD patients.
The the modified Clermont score...
11/11/2024
Advances in Inflammatory Bowel Disease Network
News
MRE or IUS for Crohn’s Disease Imaging?
11/06/2024
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients typically preferred intestinal ultrasound for diagnosis and monitoring of Crohn’s disease, while magnetic resonance enterography may be better for diagnosing relapse.
Investigators found patients...
11/06/2024
Advances in Inflammatory Bowel Disease Network
News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
10/21/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
10/21/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Drs James Lewis and Laura Raffals on SPARC
10/21/2024
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...
Dr Raymond Cross hosts Drs James...
10/21/2024
Advances in Inflammatory Bowel Disease Network
Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use